Bi-Daily Stock Overview
Middle East Pharmaceutical Industries Co. at 116.60, -1.02% today, +4.25% over five days, +3.19% year-to-date. Volume subdued at 0.3x average. The session recorded 798 trades at 0.3x normal volume. Price is trading 0.66% below intraday VWAP at 117.37.
Flow indicates alignment: strong buy-side pressure confirmed by smart money neutral. Order flow and smart money signals are aligned positively, reflecting broad participant agreement. Risk profile is moderate: defensive beta (0.85) with moderate volatility. Risk texture shows max drawdown at 12.5% with Sharpe ratio at 3.81.
Stochastic is overbought at 80.4 while RSI remains neutral-high at 68.4. Trend strength is strong in the sideways direction. Price is contained between support at 116.37 (0.2% below) and resistance at 119.57 (2.5% above). Support sits 0.2% below current price while resistance is 2.5% above. Within the 52-week range (108.0–140.6), price is 17.1% below the high.
The information environment is quiet with no tracked headlines. News mix is neutral: 0 positive vs 0 negative items over 7 days from 0 total tracked. Scale anchor: market cap is 2.2B SAR in the PHARMA,_BIOTECH_AND_LIFE_SCIENCE sector.
Positioning reflects rank 2 of 3 in PHARMA,_BIOTECH_AND_LIFE_SCIENCE, trailing TASI by 4.32% YTD. Against a sector average daily return of 0.46%, the stock's daily return measured 0.49%, an outperformance of 0.03 percentage points. Note: intraday change and daily return measures differ due to calculation basis. Watch which boundary gets tested: 116.37 or 119.57.
Flow:
POSITIVE
Levels:
IN RANGE
Risk:
MODERATE
Watch which boundary gets tested: 116.37 or 119.57.
Informational only. Not financial advice.